Patents Assigned to LeanGene AB
  • Patent number: 7217692
    Abstract: The present invention relates to complexes of the FOXC2 protein with other proteins, in particular complexes of FOXC2 with proteins designated p621, NOLP, HSC71, FTP3, CLH1, and Kinase A Anchor Protein 84/149 (AKAP). The protein complexes can be used in methods of identifying agents useful for the treatment of medical conditions that can be treated by modulated FOXC2 activity, such as obesity, hypertriglyceridemia, diet-induced insulin resistance, and/or type 2 diabetes.
    Type: Grant
    Filed: January 28, 2003
    Date of Patent: May 15, 2007
    Assignee: LeanGene AB
    Inventors: Isabel Climent-Johansson, Sven Enerbäck